ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 682237 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 682237; 2) Community: the network communities that were significantly associated with the response to NSC 682237; 3) Molecule: the relationships between components within communities and NSC 682237; 4) MDR: the compounds that were significantly associated with the NSC 682237.

NSC Compound Enrichment Correlation
NSC 709482 Null 0.0421163101172308 -0.060648679
NSC 710272 Null 0.0421163101172308 0.045959434
NSC 757946 (1R,2E,6R,10E,11aS,13S,14aR)-1,13-dihydroxy-6-(2-hydroxyethyl)-6,7,8,9,12,13,14,14a-octahydro-1H-cyclopenta[f][1]oxacyclotridecin-4(11aH)-one 0.0421163101172308 -0.02754779
NSC 760978 Null 0.0421163101172308 0.27357991
NSC 173905 Pentanamide, 2-(acetylamino)-N-[3-chloro-2-oxo-1-(phenylmethyl)propyl]-4-methyl- 0.0461160768969335 -0.033078647
NSC 267461 Nanaomycin 0.0461160768969335 0.011693078
NSC 406666 Null 0.0461160768969335 -0.082436839
NSC 618857 4-Piperidinone, 3,5-bis[[(4-methylthio)phenyl]methylene]-, hydrochloride 0.0461160768969335 0.27138277
NSC 627371 2,1,3-Benzoselanadiazole, nitro-6-(trifluoromethyl)- 0.0461160768969335 -0.0087269854
NSC 641052 Platinum, dichloro[(phenylmethyl)methylsulfinyl]- 1-quinolinyl-, (SP-4-1) 0.0461160768969335 -0.015556772
Total:42  Current:40    [First] [Prev] [Next] [Last]